An estimated $344 billion has been illegally removed from the Indian economy between 2002 and 2011
Indian government has extended price caps to 39 more medicines ranging from commonly used diabetes drugs to antibiotics.
Drugs under exemption make up roughly 95 per cent of the antiretrovirals used by India's AIDS patients
Few drugs in the market are not approved by the authorities and can be life-threatening.
Foreign money has been pouring into India's fast-growing e-commerce sector, with investors ranging from Japan's Softbank Corp to Singapore's Temasek Holdings.
GVK Biosciences is the latest Indian firm to come under international scrutiny over quality issues.
Sahara chief Subrata Roy may not come out clean in the biggest ever investment fraud that he allegedly did few years ago.
Sun Pharma open to large acquisitions post Ranbaxy.
Spanish bank denies credit line to bail Sahara boss.
The Supreme Court on Monday gave conglomerate Sahara another three months to come up with a final proposal to raise funds against its assets to secure bail for its founder Subrata Roy, who has been held in a New Delhi jail for more than a year. Sahara has made several failed attempts to raise $1.6 billion in bail money. Roy was jailed after Sahara failed to comply with a court order to refund billions of dollars to investors in a bond programme that was ruled illegal. The Supreme Court last week gave Sahara, a sprawling conglomerate that ranges from property to Formula One motor racing, a final chance to raise funds in order to bail out Roy. On Monday, the country's top court allowed Sahara to sell part of its Aamby Valley township outside Mumbai, which has luxury villas and a golf course, to raise funds.
The top court last week gave Sahara a final chance to raise funds.
As billions of dollars flow into India's booming online economy, some investors are beginning to fret that soaring valuations could hamper market listings.
Sahara told the top court this week it was considering other proposals to raise funds, including selling a luxury development outside Pune.
Sahara relied on a letter from bank saying the funds were there.
Novartis said it is partnered with generic drugmaker Lupin Ltd to sell the drug in India
Xiaomi said in a statement that "it isn't easy" to build up a patent portfolio as a start-up company, but it aims to have filed 8,000 applications by 2016.
The new drugs to come under price control include commonly-used antibiotics and painkillers
India's antitrust regulator has approved Sun-Ranbaxy deal, subject to the companies divesting seven products.
Shares in ITC Ltd , India's largest cigarette maker, closed 5.2 per cent lower in a broader Mumbai market that fell 0.8 percent.
Some Indian generic drugmakers are, however, uncertain about the pace of approvals in the near future.
© 2025 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances